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Abstract 
The adult mammary gland undergoes dynamic changes during puberty and the 
postnatal developmental cycle. The mammary epithelium is comprised of a bilayer of 
outer basal, or myoepithelial, cells and inner luminal cells, the latter lineage giving rise 
to the milk-producing alveolar cells during pregnancy. These luminal alveolar cells 
undergo Stat3-mediated programmed cell death following the cessation of lactation. It 
is established that immune cells in the microenvironment of the gland have a role to 
play in both ductal outgrowth during puberty and in the removal of dead cells and 
remodelling of the stroma during the process of post-lactational regression. However, 
most studies have focussed on the role of the stromal immune cell compartment or 
have quantified immune cell populations in tissue extracts. Our recent development of 
protocols for deep imaging of the mammary gland in 3-dimensions (3D) has enabled 
the architectural relationship between immune cells and the epithelium to be examined 
in detail and we have discovered a surprisingly dynamic relationship between the 
basal epithelium and leukocytes. Furthermore, we have observed morphological 
changes in the myoepithelial cells, as involution progresses, that were not revealed by 
previous work in 2D tissue sections and whole tissue. This dynamic architecture 
suggests a role for myoepithelial cells in the orderly progression of involution. We 
conclude that deep imaging of mammary gland and other tissues is essential for 
analysing complex interactions between cellular compartments.  
Introduction 
The mammary gland is somewhat unusual in that most of its development takes place 
in the adult, with newborn mammals having a simple rudimentary branched network 
of ducts emanating from the nipple region1. Subsequently, the gland undergoes 
distinct phases of development primarily in response to hormones. At the onset of 
puberty, large club-shaped structures called terminal end buds (TEBs) arise at the tips 
of the ducts and invade the fat pad, elongating and bifurcating until the limits of the fat 
pad are reached whereupon they regress to be replaced by terminal duct structures. 
In adult mice, the mammary gland undergoes a cycle of proliferation and regression 
with each ovarian cycle in response to changing levels of oestrogen and 
progesterone2,3. During diestrus, following ovulation, alveolar buds form on secondary 
branches and are subsequently removed if pregnancy does not occur2. Pregnancy 
hormones induce another phase of rapid growth marked by secondary branching and 
the formation of lobuloalveolar structures at their tips which differentiate to produce 
milk during lactation. Upon the cessation of lactation, the alveolar structures are 
removed by programmed cell death4-8 with concomitant tissue remodelling. Stromal 
reorganisation involves enzymes such as matrix metalloproteinases (MMPs)9, with 
MMP2, MMP3 and MMP9 downregulated in the absence of epithelial Stat3 
signalling10.  
The mammary epithelium comprises a simple branched bilayer of basal myoepithelial 
cells that contact the stroma and support an inner layer of luminal cells that line the 
duct1.These cells can be distinguished microscopically by their shape and by 
expression of specific intermediate filaments that allow them to be unambiguously 
identified. For example in mice, keratin 5 (K5) and keratin 14 (K14) are expressed in 
only the basal lineage while keratin 8 (K8) and keratin 18 (K18) are restricted to the 
luminal lineage and are thus utilised as surrogate markers of their respective 
lineages11. The luminal cells may also be delineated by their expression of E-cadherin, 
whilst the smooth muscle actin isoform alpha-actin (SMA) can be used to identify basal 
cells12. In two-dimensional studies in other rodent species, the myoepithelium can also 
be seen to exhibit morphological changes with the mammary postnatal developmental 
cycle, including extension of processes during pregnancy and cytoplasmic vacuolation 
after weaning13,14. A fully involuted gland morphologically resembles a virgin gland 
although has a higher density of side branches15.  
 
Throughout these dramatic cycles of growth and tissue re-organisation, the stroma 
and the immune cell compartment are dynamically altered and immune cells vary in 
frequency and type at different mammary postnatal developmental time points. 
Macrophages have been demonstrated to play a critical role in the mammary 
microenvironment during postnatal development, including regulation of branching 
morphogenesis. While macrophages, eosinophils and mast cells surround the TEBs 
that arise during puberty, T and B lymphocytes are notably absent16-18. In non-
pregnant female mice, the highest numbers of macrophages are present in diestrus 
although a larger number are in direct contact with the epithelium during proestrus19-
21. Macrophages also play a fundamental role during mammary postlactational 
regression10,21-23 when active Stat3 signalling in the mammary epithelium is critical in 
the development of an immunomodulatory phenotype in these cells24. This contributes 
to the overall acquisition of a ‘wound healing’ signature in the mammary gland25,26. 
Interestingly, recent studies have demonstrated that foetal-derived macrophages 
predominate in mammary gland stroma of the adult27 while NOTCH-expressing 
macrophages have been shown to interact with basal mammary stem cells expressing 
the delta-like 1 NOTCH ligand to promote their expansion28. Thus, proper postnatal 
development of the mammary gland requires an associated population of tissue-
resident macrophages. 
 
Similarly to macrophages, eosinophils fulfil an important role in mammary gland 
development, both in mice16 and in species such as cows that possess terminal 
ductulo-lobular units rather than TEBs29. Eosinophil recruitment to the prepubertal 
mouse mammary gland coincides with a dramatic increase in eotaxin mRNA transcript 
levels and, like macrophages, eosinophils are thought to promote branching and 
formation of TEBs16,17. Mast cells also exhibit fluctuations in number during different 
stages of mammary postnatal development30,31 and numbers present during murine 
involution are influenced by mammary epithelial Stat3 signalling10,23. Elaboration of 
plasma kallikrein, a plasminogen activator, may be one role of the connective-tissue 
type mast cells associated with postlactational regression18. The mammary immune 
microenvironment also includes CD3-positive T lymphocytes32 and the presence of 
plasma cells has been demonstrated25, correlating with historical studies highlighting 
the presence of IgA in the mammary gland during involution33. Recently, the similarity 
between the mammary gland and mucosal tissues has been emphasised and the 
presence of populations of functionally distinct subtypes of T lymphocytes and 
dendritic cells has been delineated34.  
To date, the majority of studies of immune cells in the mammary gland have relied on 
flow cytometry and histological studies of tissue sections, and while these have 
provided insights into the numbers and identity of immune cells present in mammary 
tissue, they have not provided detailed information on their relationship with the 
luminal or basal epithelium nor their architectural arrangement within the tissue. We 
sought to address these questions by utilising our recently developed tissue clearing 
and deep tissue imaging protocols based on those developed by Susaki and 
colleagues35-39. Our observations revealed a surprisingly dynamic relationship 
between immune cells and the myoepithelial compartment and the intimate 
connections between the vascular and ductal epithelial networks. 
Results 
Our recent optimisation of tissue clearing and imaging of the mammary gland enables 
in situ visualisation of the ductal system and its surrounding stroma in 3-dimensions 
(3D)36. We sought to use these approaches to investigate epithelial morphogenesis 
throughout a pregnancy/lactation/involution cycle. Here we consider this tissue 
remodelling in the context of the intact mammary stroma, focussing on immune cells 
and their interplay with the epithelial network.  
Association of CD45+ cells with the mammary epithelium in virgin mice. 
We initially examined whole mammary tissue from adult virgin mice, in which the ductal 
system is fully expanded to fill the fat pad and TEBs have regressed. Maximum 
intensity projection (MIP) of SMA stained glands highlighted the varying extent of 
ductal side-branching and alveolar budding that is observed in post-pubertal mice (Fig. 
1A). Although 2D imaging can be sufficient to demonstrate broad changes in 
branching morphogenesis and alveolar budding across the estrous cycle, as has been 
shown previously40,  here we highlight the importance of deep imaging analyses which 
do not depend critically on the plane of section, and where the relationship between 
buds and branches is much more visually apparent. We noted also the precise 
orientation and high density of the long, thin basal myoepithelial cells that run in 
parallel to the direction of ductal elongation (Fig. 1B iii). This organised arrangement 
may provide strength and elasticity to the ducts enabling their expansion when they 
are engorged with milk during lactation. Notably, the myoepithelial cells are re-
orientated at branch points and at the tips of branches (Fig. 1A-B). 
Immune cells have previously been described in the stroma, closely associated with 
the ductal epithelium and particularly at the tips of growing ducts, around the TEBs. 
However, numbers of many of these cells, including eosinophils and mast cells, 
decline in parallel with the regression of the TEBs41. Furthermore, fluctuations in 
estradiol and progesterone during an ovarian cycle have been shown to influence 
immune cell populations in the mammary gland20. Thus, we sought to determine the 
distribution of immune cells in fully developed adult mammary glands of virgin mice 
using the pan-leukocyte marker CD45 (lymphocyte common antigen). We noted a 
striking distribution of CD45+ cells that appear to be distributed throughout the ductal 
epithelium (Fig. 1B) with individual cells exhibiting an intimate relationship with the 
basal epithelium (Fig. 1B ii, iii). On closer inspection using sequential optical slices, it 
became apparent that CD45+ cells are intercalated between the epithelial bilayer of 
the ducts (Fig. 1C-E). Importantly, CD45+ cells are rarely observed within the lumen 
of the ducts. Of note, many of the CD45+ cells observed in virgin mice have a dendritic 
morphology (Fig. 1D) with processes frequently stretching along the interface between 
the basal and luminal layers (Fig. 1E). 
DAPI staining of nuclear DNA highlights the large number of cells (both CD45 positive 
and negative) within the stroma, including adipocytes, fibroblasts, and cells comprising 
the blood and lymphatic vessels (Fig. 1A, C). Although SMA also delineates ducts of 
the vascular network (Fig. 1Bi), the distinctive arrangement of the actin network, which 
encircles these vessels rather than running along their length, allows them to be clearly 
distinguished from the mammary ducts. 
We also noted that each individual side branch or bud frequently has at least one 
associated CD45+ cell (Fig. 1 F, G). Previous work showed that CD11c+ cells 
(encompassing dendritic cells and a subpopulation of macrophages) play an inhibitory 
role in branching morphogenesis42. This suggested to us that CD45+ cells could be 
important components of the ductal architecture during a pregnancy cycle and this 
prompted us to investigate the distribution of immune cells in lobuloalveolar structures 
during lactation.   
Association of CD45+ cells with the mammary epithelium in lactating glands. 
Pregnancy results in a massive expansion of the mammary epithelium and the fat pad 
becomes filled with lobuloalveolar structures that cluster at the tips of tertiary 
branches. At the onset of lactation, a final round of proliferation takes place and the 
majority of mammary epithelial cells then exit the cell cycle and become secretory 
milk-producing cells1. Immunostaining for SMA revealed that the basal cells 
surrounding alveoli adopt a completely different shape to those in the ducts with a 
central nucleus and cytoplasmic extensions forming a stellate shape (Fig. 2A i, ii and 
iii)36. Several myoepithelial cells encompass each lobule, forming a basket-like 
network35. This arrangement of myoepithelial cells is necessary for their contraction 
(in response to oxytocin) to expel milk into the ducts43,44.  Indeed, genetic deletion of 
the SMA-alpha isoform encoded by the Acta2 gene results in diminished contractility 
of myoepithelial cells and reduced ejection of milk45. 
Immunostaining for CD45+ cells revealed that these cells have a different morphology 
to those in the ducts of virgin mice. During lactation, many leukocytes seem to be 
closely associated with the myoepithelial cells; the cells appear to co-localise, often 
lying adjacent to one another, and adopting the same shape (Fig. 2A-B). Sequential 
thin optical sections through a single alveolus (Fig. 2C) show that CD45+ cells appear 
to intercalate between the overlying basal cells and the luminal cells, which are 
frequently binucleate in the lactating mammary gland32,46,47. A comparison of cells in 
the virgin ducts with those in the alveoli (compare Fig. 1B ii with Fig. 2A ii) reveals a 
striking increase in the preponderance of CD45+ cells with a dendritic-like morphology 
during lactation, the majority of cells exhibiting extensive, fine cytoplasmic processes. 
In other tissues, it is well established that dendritic cells can extend their cytoplasmic 
processes through even the tight junctions between epithelial cells to sample antigen. 
Thus their localisation between the myoepithelial and luminal layers, and the 
increased frequency of dendritic-shaped cells during lactation, may reflect enhanced 
immunosurveillance at this time. 
Dynamic association and re-arrangement of CD45+ cells during involution of the 
mammary epithelium. 
At the cessation of lactation, a programme of cell death, coupled with tissue 
remodelling and re-differentiation of the fat pad adipocytes is initiated48. This process 
ultimately returns the gland to a near pre-pregnant state. Within 12h of forced 
involution, luminal epithelial cells are stochastically induced to undergo programmed 
cell death and by 72h after forced involution, the alveoli are visibly collapsing and lipid-
filled adipocytes are apparent49. It is well established that involution is associated with 
an influx of macrophages and other immune cell types that are thought to be an 
essential component of the involution process22. However, involution has not been 
visualised in 3D and thus we therefore carried out an analysis of involution at 5 
timepoints over an 11 day time course with a focus on the basal epithelial and CD45+ 
cells, their morphology and their localisation.  
At 24h involution, the architecture of the gland is very similar to that in lactation and 
lobules are fully expanded (Fig. 3A). The lumens of the alveoli at this time are 
characterised by accumulation of milk, milk fat globules and dying cells that have been 
shed from the alveolar structure. As involution progresses, subtle changes in the 
myoepithelial cells are observed at 48h (Fig. 3B), the time when the progression to 
irreversible involution occurs50. This slight condensing of the myoepithelial cells at 48h 
is more apparent by 72h involution, where the collapse of the alveolar structures is 
obvious and the myoepithelial cells, while maintaining their shape, are shorter and 
more condensed (Fig. 3C). More dramatic changes take place subsequently and by 6 
days involution, the actin filaments are highly condensed and disorganised and the 
alveolar structures are contracted, shrinking towards the ducts (Fig. 3D). By 11 days 
involution, these condensed alveoli are still present, although they are substantially 
reduced in size (Fig. 3E). 
The arrangement and morphology of CD45+ cells also changes as involution 
progresses. Notably, at 24h, these cells are still associated with the myoepithelial cells 
and their morphology is very similar to those present during lactation (Fig. 3A). By 48h 
involution, while many leukocytes are dendritic in shape, their processes are shorter 
than those seen at 24h, possibly reflecting the condensing of the basal cells of the 
contracting alveoli (Fig. 3B). At 72h involution, there are visibly more CD45+ cells and 
these associate with the alveoli, often, but not always, colocalising with myoepithelial 
cells (Fig. 3C). By 6 and 11 days involution the CD45+ cells are more round with fewer 
cytoplasmic processes and their morphology more closely resembles that of the 
CD45+ cells observed in the virgin gland (Fig. 3D-E). In order to examine these 
populations of cells further, we immunostained with various markers for specific types 
of immune cells. 
Considering the dendritic morphology of the CD45+ cells, we first looked for dendritic 
cells (DCs) using CD11c. However, we had observed in virgin mice, that whilst these 
cells were present (Fig. 4A), they could not account for the majority of CD45+ cells 
observed. Thus we hypothesised that most of the dendritic-shaped CD45+ cells 
present during involution are likely to be macrophages. Unfortunately, none of the 
macrophage markers examined were compatible with the tissue clearing protocol, 
except for major histocompatibility complex class II (MHCII), which is upregulated on 
both activated DCs and macrophages. In virgin mice, the pattern of MHCII expression 
was similar to that seen using CD45 (Fig. 4B), therefore we used MHCII expression 
for analyses during involution time-points. At both 24h and 72h involution, MHCII+ 
cells are abundant within the alveolar structures and staining for MHCII closely 
resembles that seen for CD45 (Fig. 4C-D) although does not fully account for all the 
CD45+ cells present.  
To determine whether immune cells intercalate between the epithelial layers during 
involution, we examined individual z slices. At 72h post-weaning, CD45+ cells are 
predominantly found adjacent to the basal cells, suggesting they reside between the 
two layers (Fig. 4E). Notably, only very few CD45+ cells were observed within the 
alveolar lumen at this time. At 6 days involution, immune cells are clearly observed in 
the alveolar lumen, in addition to their localisation in the intra-epithelial space (Fig. 
4F). This may indicate a loss of the integrity of the luminal layer or migration of the 
CD45+ cells into the luminal space where they could carry out a phagocytic function.  
Imaging in 3D reveals the multifocal nature of the involution process in 
mammary gland. 
The multifocal nature of involution is apparent even in a forced involution where 
suckling pups from normalised litters are removed at the peak of lactation. Figure 5A 
demonstrates the varying extent of involution progression that can be observed at 72h 
within a single gland. Note the fully expanded lobuloalveolar clusters in (i) relative to 
the much more collapsed structures in (ii) and (iv). This might suggest that dying cells 
secrete a cytokine or other signal that acts in a paracrine manner to induce the death 
of other cells within the alveolar cluster. The specific activation of Stat3 within 12 hours 
of forced involution, and the requirement of LIF51 and subsequently oncostatin M52 for 
this activation, would support this contention.  
Myoepithelial cells are very difficult to see in H&E sections during lactation and 
involution (Fig. 5B i-ii) unless they are immunostained (Fig. 5B iii-iv) and it is practically 
impossible to detect the architectural changes in the myoepithelial cells during 
involution with such 2D imaging tools. Using our 3D imaging approach, myoepithelial 
cells are very easy to visualise and, for the first time, we have an understanding of 
their dynamic nature in situ. This facilitated the unexpected discovery that 
myoepithelial cells do not, in fact, die concomitantly with the luminal cells during 
involution. Instead, they change shape as the alveoli contract with loss of the luminal 
cells, in a previously unrecognised retreat towards the ductal tree (Fig. 5C) where 
elongated myoepithelial cells appear to become incorporated into the parallel strands 
of the ducts (Fig. 5D) or remain as small outpouchings (Fig 5D ii-iii). 
This striking change in the size and shape of basal alveolar cells indicates that they 
may not be ‘neutral’ bystanders in the involution process. Presumably the mechanism 
of luminal cell death (whereby the uptake of milk fat droplets leads to lysosomal 
membrane permeabilisation)5 does not occur in myoepithelial cells and instead, these 
cells may realign with the ducts in preparation for a subsequent pregnancy. Since 
myoepithelial cell morphology provides a useful marker for the progression of 
involution, we suggest that involution studies could include 3D analyses to avoid any 
misinterpretation resulting from the multifocal nature of this remodelling programme.  
Finally, as we have previously shown, this imaging approach enables the visualisation 
of tissue vasculature. In virgin glands and during involution, a close juxtaposition of 
vascular (Fig. 6A-C)  and putative lymphatic networks (Fig. 6D) is apparent. This 
highlights the potential of deep tissue imaging for investigating the interactions 
between the epithelial tissue and components of the microenvironment. 
Discussion 
The interplay between epithelial cells and immune cells in tissues such as lung and 
gut is well established. In mammary gland, while immune cells have been observed to 
be localised in close proximity to basal epithelium and in mammary tumours within the 
tumour epithelium, a comprehensive study using deep imaging has not been 
previously undertaken. Using our established protocols to address this issue, we made 
a number of notable, and unexpected, observations. The first of these is the dramatic 
difference in the morphology of both the myoepithelial and CD45+ cells at different 
stages of postnatal development. In virgin glands, the basal cells are aligned parallel 
to each other and in the direction of ductal elongation. Re-orientation of this 
myoepithelial cell layer occurs at branch points and at the ductal tips. In this context it 
is worth noting that myoepithelial cells have been shown to suppress the invasion of 
tumour cells possibly through the production of proteases and anti-angiogenic 
factors53 and can restrain the escape of tumourigenic luminal cells in organoid 
cultures54. Furthermore, while the myoepithelial cell layer is intact in ductal carcinoma 
in situ (DCIS), loss of myoepithelial cells is associated with invasive breast cancer. 
These findings suggest that myoepithelial cells are dynamically involved in maintaining 
the architecture of the normal gland, a notion that is supported by our observation of 
the dynamic change in shape of myoepithelial cells as involution progresses. Our 
ability to visualise intact ductal structures should facilitate analysis of the role of 
myoepithelial cell loss in the transition of DCIS to invasive breast cancer.  
CD45+ cells are distributed throughout the stroma as expected but also appear 
attached to the ducts within the epithelial bilayer, where most lie between the basal 
and luminal epithelial cells. The considerable number of intercalated cells in the ducts 
of virgin mice raises the question as to the origin of these CD45+ cells. It could be 
argued that the number of leukocytes, and their pattern of distribution, suggests that 
the intercalated CD45+ cells arise from a pool of immune cell progenitors that are 
resident in the mammary gland and proliferate along with the epithelial cells as the 
duct elongates. Indeed, proliferation of CD11c+ antigen presenting cells has been 
shown to occur in mammary organoids over a period of 15 days in culture42. However, 
orchestrated recruitment from the periphery or stroma under the influence of the 
exquisitely balanced cytokine milieu of the mammary microenvironment is an 
alternative hypothesis requiring investigation. What is irrefutable is that the rapidly 
changing epithelial branching morphology during oestrus and pregnancy cycles 
requires a dynamic response in the immune cell compartment. Leukocytes are 
essential for postnatal development of the mammary gland as their depletion, by 
irradiation, results in a failure of normal glandular development16. 
The intercalation of immune cells within the bilayered mammary epithelium raises the 
question as to their function, which we consider likely multifactorial. One possibility is 
that immune cells provide immune surveillance as the ducts are open to the 
environment through the nipple region allowing infiltration of bacteria and other 
infectious or noxious agents should there be a breach of the innate immune barrier of 
the teat canal. Another possibility is the production of cytokines that are required for 
ductal outgrowth. 
In lactating mammary glands, we observed that the morphology of both the 
myoepithelial and CD45+ cells is dramatically different from their counterparts in the 
ducts of virgin mice. The basal cells no longer align but adopt a stellate shape that 
forms a complex web overlying the alveolar luminal cells in each bud. While this 
morphology has been described before35, we were surprised to observe that the 
majority of the CD45+ cells have the same shape. While some more rounded cells 
were apparent, frequently the CD45+ cells closely mirrored the overlying myoepithelial 
cell. This could suggest that these cells are in physical contact through receptor 
binding and may communicate directly or indirectly via paracrine signalling. We note 
that the cytoplasmic processes appear to protrude through the luminal layer where 
they will be able to sample the alveolar lumen.The expression of MHCII on many of 
these cells suggests that they are active antigen presenting cells. Progesterone has 
been shown to regulate the Th1/Th2 phenotype of T cells and induces Th2 cytokines 
during pregnancy55. Interestingly, although alveologenesis is delayed in pregnancy, 
lactation occurs normally in mice that are deleted for Stat6 or double deleted for IL-4 
and IL-13, suggesting that Th2 cytokine signalling is not required for lactation56. In 
contrast, Th1 signalling and CD4+ T helper cells are required for development during 
puberty42.  
 
Involution of the mammary gland is associated with upregulation of Stat3 and NF-B 
signalling that are undetectable in late lactation, and a dramatic increase in the 
expression of acute phase response genes such as serum amyloid A1 and A2 and 
orosomucoids, many of which are Stat3 targets10,57. Furthermore, previous microarray 
analyses of involution time points by us and others, revealed upregulation of immune 
mediators during post-lactational regression25,26. The massive cell death that occurs 
during the first 4 -5 days of involution requires the rapid removal of dead cells, milk fat 
globules and milk protein and, following the initial reversible cell death phase, an influx 
of macrophages occurs around 72h involution. Prior to this, the luminal mammary 
epithelial cells undergo a cell fate switch and becomes non-professisonal phagocytes 
(or efferocytes) and these cells are responsible for the uptake of milk constituents and 
dead luminal cells, a process that usually results in their demise5. It is thus not 
surprising that the morphology, and possibly the identity, of the CD45+ immune cell 
population changes as involution progresses and may reflect the changing populations 
of immune cells that have been described10,22. 
The few studies that have been carried out on mammary gland blood and lymphatic 
vasculature have shown that both vessel types are closely apposed to the mammary 
ducts with the former also penetrating the alveolar buds while the lymphatic network 
does not58. Neo-lymphangiogenesis has been shown to occur during involution of the 
mammary gland in concert with upregulation of VEGF-C, VEGF-D, and their 
receptors59. A recent study showed that the GPI-anchored membrane glycoprotein 
semaphorin 7A (SEMA7A) is expressed in the mammary epithelium during involution 
and suggested that SEMA7A may play a role in macrophage-mediated 
lymphangiogenesis60. There is, however, some discrepancy in the literature with 
different investigators reporting maximum lymphatic vessels density at different stages 
of the pregnancy cycle58,61. We therefore propose that tissue clearing be utilised in 
future studies to properly assess the nature of the relationship between the mammary 
epithelium and its vasculature, which is only revealed by deep tissue imaging. Our 
observation that vascular networks run along the mammary ducts (Fig. 6C) is in accord 
with ultrastructural studies in rat mammary glands62. 
This study has highlighted the level of detail that is missed in conventional histological 
studies and reveals the necessity for deep 3D imaging in intact tissue to fully 
appreciate complex interactions between tissue structures, particularly those 
undergoing dramatic changes in response to hormonal fluctuations. We anticipate that 
our work will lay the foundation for further studies that address the interplay between 
mammary epithelium and its environment and how this changes during cycles of 
development in the adult and during the progression of breast tumourigenesis.  
Materials and Methods 
Reagents 
The following reagents were purchased from Sigma Aldrich: phosphate buffered saline 
(PBS), sodium azide, neutral buffered formalin (NBF), NaCl, urea, N,N,N’,N’-
tetrakis(2-hydroxypropyl)ethylenediamine, sucrose, 2,2′,2″-nitrilotriethanol and ,3′-
Diaminobenzidine (DAB). Triton-X100 was purchased from VWR International. 
Imaging dishes were purchased from Ibidi (81158). Normal goat serum (NGS) was 
purchased from Abcam (ab7481). 4′,6-diamidino-2-phenylindole, dilactate (DAPI) was 
purchased from Invitrogen (D1306). 
 
Animals 
BALB/c mice were purchased from Charles River, Harlow, UK at 6-7 weeks of age. 
C57BL/6 mice were bred in-house at the Biological Services Unit, Department of 
Pathology, University of Cambridge. Unless stated, all mice used were BALB/c. 
Animals were housed in individually ventilated cages under a 12:12 hour light/dark 
cycle with food and water available ad libitum. Experiments were performed according 
to the Animal (Scientific Procedures) Act 1986, and the European Union Directive 
86/609, and were approved by the local ethics committee. Group sizes were not 
predetermined using any statistical methods. 
 
Involution studies 
Females (8 weeks old) were mated in trios using C57BL/6J male studs; after 2 weeks, 
males were removed, and females housed individually. Litters were normalised within 
3 days of birth to 6-9 pups per dam. After 10 days (range 9-11) lactation, pups were 
removed and killed. Dams were co-housed during the involution period and were 
harvested after 1-11 days. All mice were killed by dislocation of the neck. Excised 
mammary glands were spread on Tetra Pak card and fixed in 10% NBF overnight at 
4oC. Fixed tissues were stored in PBS containing sodium azide (0.05% (w/v)) for up 
to 16 weeks. For all virgin time-points, mice were 8-12 weeks old and were not estrous-
staged. Lactating mice were harvested after 10 days (range 9-11) lactation. 
 
Optical tissue clearing and immunohistochemistry 
Tissues were optically cleared using the CUBIC protocol as described previously36. 
CUBIC reagent 1A contained the following: urea (10% (w/w)), N,N,N’,N’-tetrakis(2-
hydroxypropyl)ethylenediamine (5% (w/w)), triton-X100 (10% (w/w)) and NaCl 
(25 mM) in distilled water; CUBIC reagent 2 contained: sucrose (44% (w/w)), urea 
(22% (w/w)), 2,2′,2″-nitrilotriethanol (9% (w/w)), triton-X100 (0.1% (w/w)) in distilled 
water; blocking buffer contained NGS (10% (v/v) and triton-X100 (0.5% (w/v) in PBS. 
 
Tissues were cut into small pieces ( 10 of 10 x 1 mm) and were immersed in CUBIC 
reagent 1A for 3 days at 37oC with gentle agitation (solution refreshed daily). Samples 
were blocked in blocking buffer overnight at 4oC (with gentle rocking). Primary 
antibodies were diluted in blocking buffer and samples were stained for 4 days at 4oC 
(gentle rocking). Samples were washed (PBS containing triton-X100 (0.1% (w/w)) (3 
x 1 hour) at room temperature (with gentle agitation) prior to incubation with secondary 
antibodies for 2 days (4oC; with gentle rocking). Samples were washed and incubated 
with DAPI (10M) for 2 hours (room temperature). Samples were immersed in CUBIC 
reagent 2 for at least 24 hours at 37oC (with gentle agitation) and were imaged within 
1 week. Primary antibodies were omitted from this procedure to ensure detected 
staining was antibody-specific. 
For 2-dimensional analysis, mammary glands were fixed in 10% NBF and were 
processed and stained with haematoxylin and eosin (H&E), following standard 
protocols. For immunohistochemistry, antigen retrieval was performed using a PT Link 
system (Agilent) according to standard procedure.  
 
Confocal microscopy 
Tissues were imaged in Ibidi -dishes using a Leica SP8 inverted confocal microscope 
with 10x/0.4 and 20x/0.75 HC PL APO objective lenses. Laser power and gain were 
manually set for each fluorophore, enabling optimal fluorescence with minimal 
photobleaching. Images were processed as maximum intensity projections (MIPs) 
using ImageJ (version 2.0.0 National Institutes of Health). Image depths are shown 
from the top of the recorded image (typically 350 m through the fat pad)36. 
 
Antibodies 
The following primary antibodies were used for immunostaining of optically cleared 
tissues: polyclonal rabbit anti-α-smooth muscle actin (SMA) (Abcam, ab5694; 1:300); 
and from BioLegend: rat anti-CD45 clone 30-F11 (103102; 1:300), CD11c clone N418 
(117302; 1:200), MHCII I-A/I-E clone M5/114.15.2 (107601; 1:300). The following 
macrophage markers were found to be unreliable with the tissue clearing protocols 
used: rat anti-F4/80 (clone BM8), rat anti-CD11b (clone M1/70), rat anti-CD68 (clone 
FA-11) (all from BioLegend), and rat anti-F4/80 (clone Cl:A3-1; from AbD Serotec). 
The following secondary antibodies (all used at 1:500) were purchased from 
Invitrogen: goat anti-rabbit Alexa-fluor 488 (A11008), goat anti-rat Alexa-fluor 647 
(A21247), goat anti-rat Cy3 (A10522); and Jackson ImmunoResearch: Goat anti-
Armenian hamster Cy3 (127-165-160). 
For 2D analysis, SMA expression was detected using a mouse anti-human SMA 
primary antibody (clone 1A4, Agilent; M0851) with a peroxidase-conjugated 
ImmPRESS anti-mouse IgG polymer detection kit (Vector Laboratories; MP-7402) 
using standard development with DAB. Mouse IgG1 was used for species- and 
isotype- matched control (Agilent; X0931). 
 
Statistics 
No statistical analyses were performed. 
 
Data availability 
Original confocal image data can be made available by contacting the 
corresponding author.  
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Leukocytes localise to mammary ducts and reside in the intra-epithelial bilayer 
Three-dimensional (3D) confocal microscopy of optically cleared virgin mammary glands from 
BALB/c mice were immunostained for the myoepithelial cell marker smooth muscle -actin 
(SMA) (magenta), the pan-leukocyte marker CD45 (cyan), and nuclei were stained with DAPI 
(grey). A) 3D maximum intensity projections (MIPs) of the entire image sequence captured 
where the larger panels (i-iv) show the merge of individual SMA and DAPI stains (smaller 
panels); B) MIPs of a primary mammary duct; with single stains shown below the main panel. 
Higher magnification images of the boxed region are shown in each subsequent panel (i-iii); 
C) 5 individual optical slices, (0.68 m thick), through a stack with the depth (z value) relative 
to the first image in the sequence; D) MIPs of a duct; individual stains shown in the panels 
below; E) individual optical slices (0.68 m thick) through the optical stack shown in D); the 
depth (z value) is relative to the start of the image sequence; F-G) MIPs of the entire image 
sequence captured. Images are representative of 7 mice; all scale bars represent 100 m. Dt 
= mammary duct, BV = blood vessel, DL = duct lumen. 
 
Figure 2 
The distinct basal epithelial cell morphology in lactation is shared by the associated 
leukocytes 
Mammary glands from lactating BALB/c mice were optically cleared and immunostained for 
smooth muscle -actin (SMA) (magenta), CD45 (cyan), and nuclei were stained with DAPI 
(grey). A) 3D maximum intensity projections (MIPs) of the entire image sequence showing 
myoepithelial cells (top row), leukocytes (middle row) and a merged image (bottom row). 
Higher magnification images of the boxed region are shown in each subsequent panel (i-iii); 
B) MIPs of the entire image sequences of four individual alveolar clusters, each from a different 
mouse, showing overlap between the morphology of the SMA and CD45 positive cells; c) 5 
sequential optical slices (0.68 m thick) of the area shown in the boxed region in B (iv), where 
the depth (z value) is relative to the first image in the sequence. Images are representative of 
a total of 6 mice; all scale bars represent 100 m. 
 
Figure 3 
Leukocytes accumulate in the mammary gland during involution 
Mammary glands from force-involuted BALB/c mice were harvested, optically cleared and 
immunostained for smooth muscle -actin (SMA) (magenta), CD45 (cyan), and DAPI (grey). 
3D maximum intensity projections (MIPs) of the entire image stack captured are shown for 
mice harevsted at A) 24h; B) 48h; C) 72h; D) 6 days and E) 11 days after forced involution. 
Panels i, ii and iii show merged SMA and CD45 stained images; boxed regions in panel i are 
enlarged in panel ii; boxed regions in panel ii are enlarged in panel iii; individual stains of the 
merged images in panel iii only are shown. Images are representative of 4 mice (24h), 2 mice 




Leukocytes closely associate with the mammary epithelium during involution, residing 
between the luminal and basal alveolar cells 
Mammary glands from BALB/c mice were harvested at the indicated time-points after forced 
involution, optically cleared and imaged using confocal microscopy. Images in A-D show 3D 
maximum intensity projections (MIPs) of the entire sequence captured and were 
immunostained for smooth muscle -actin (SMA) in conjunction with A) CD11c (yellow) and 
B-D) MHCII (yellow); smaller images show individual stains of the merged image in the larger 
panels. E-F) Individual optical slices, (2.0 m thick), from an optical stack (E = 72h involution; 
F = 6 days involution), where the depth (z value) is relative to the first image in each sequence. 
Glands were immunostained for SMA (magenta) and CD45 (cyan). Images are representative 
of 4 mice at each time point examined ; all scale bars represent 100 m; Dt = mammary duct, 
BV = blood vessel. 
 
Figure 5 
During involution, myoepithelial cells contract towards the ductal tree while 
maintaining the structure of the alveoli 
Mammary glands from BALB/c mice were harvested at 3 and 6 days involution, optically 
cleared and immunostained for the myoepithelial cell marker smooth muscle -actin (SMA) 
(magenta) and DAPI (grey). Mammary glands harvested from C57BL/6 mice 72h after 
involution were processed by conventional histological tehniques. A) 3D maximum intensity 
projections (MIPs) of the entire image stack of four individual alveolar clusters from four 
different mice (i-iv). B) Tissue sections of mammary tissue at 72h involution were stained using 
H&E (i-ii) and anti-SMA antibody (brown) with haematoxylin counterstain (iii-iv). Boxed areas 
are enlarged in the image to the immediate right. C-D) MIPs of SMA (magenta)-stained 
mammary glands at involution day 6 demonstrating the contraction of the alveolar clusters (C) 
and their close localisation to the ductal tree (D). Images are representative of 9 mice (A), 4 
mice (B-D).  Scale bars in A, C and D represent 100 m. Scale bars in B represent 200 m (i 
and iii) and 40 m (ii and iv). BV = blood vessel. 
Figure  6 
Examples of vascular staining using 3D imaging of the adult mammary gland 
Blood and lymphatic vessels were detected using smooth muscle -actin (SMA) staining 
revealing the intricate, and contrasting, pattern of the actin cytoskeleton. Mammary glands 
from adult BALB/c mice harvested at the indicated involution time-points were optically cleared 
and imaged in 3D using confocal microscopy. All images show 3D maximum intensity 
projections (MIPs) of the entire optical sequence captured; staining for SMA (magenta), DAPI 
(grey) and CD45 (cyan). A-B) Low magnification overviews showing multiple vessel types 
present in the same field of view in A) virgin and B) 6 days involuted glands; smaller images 
show individual stains of the merged image in the main panel; C) i-iii examples of the close 
association between the vasculature and mammary ducts; D) a vessel containing many 
CD45+ cells sitting adjacent to the duct; the boxed region in the left panel is enlarged in the 
right panel; individual stains are shown to the left of the merged image. Images are 
representative of at least 4 mice for each time point shown; all scale bars represent 100 m; 
Dt = mammary duct, BV = blood vessel, LV = putative lymphatic vessel. 
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